市场调查报告书
商品编码
1301771
术中成像市场:2019-2029 年全球市场规模、份额、趋势分析、机会和预测报告Intraoperative Imaging Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Products (Mobile C Arm, Ultrasound, CT ); By Application ; By Region |
由于慢性病患病率的不断上升、诊断成像技术的进步、对微创手术的日益关注以及术中 MRI 和光学相干断层扫描等最新技术的创新,全球术中成像市场正在蓬勃发展。我来了。
领先的战略咨询和市场研究公司 BlueWeave Consulting 最近估计,2022 年全球术中成像市场规模为 2.38 亿美元。 BlueWeave预测,在2023-2029年的预测期内,全球术中成像市场规模将以13.5%的复合年复合成长率增长,到2029年将达到5.7747亿美元。对具有成本效益的医疗解决方案的需求不断增长以及门诊手术的趋势也推动了对术中成像的需求。术中成像技术可缩短住院时间并最大限度地减少重复手术的需要,从而有助于降低总体医疗成本。总体而言,对术中成像的需求不断增长,改善了手术结果,提高了患者安全性并降低了医疗成本,使其成为对医疗保健专业人员和患者越来越有吸引力的选择。此外,因癫痫和脑肿瘤等神经系统疾病而到医院寻求治疗的患者数量也在增加。据世界卫生组织称,癫痫症影响着全球超过 5000 万人,占全球疾病负担的很大一部分。一般人群中活动性癫痫的患病率估计为每 1,000 人 4-10 人。因此,慢性病患病率的增加和技术先进的成像系统的采用预计将在预测期内推动该行业的增长。
该报告的详细分析提供了有关全球术中成像市场的增长潜力、未来趋势和统计数据的信息。它还涵盖了推动市场总规模预测的因素。该报告提供了全球术中成像市场的最新技术发展以及行业见解,以帮助决策者做出明智的战略决策。它还分析了市场的增长促进因素、挑战和竞争力。
Global intraoperative imaging market is flourishing due to the increasing prevalence of chronic diseases, advancements in imaging technology, a growing focus on minimally invasive surgeries, and innovations driven by modern technologies such as intraoperative MRI and optical coherence tomography.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global intraoperative imaging market size at USD 238.0 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global intraoperative imaging market size to grow at a CAGR of 13.5% reaching a value of USD 577.47 by 2029. The increasing demand for cost-effective healthcare solutions and the growing trend toward outpatient surgeries are also driving the demand for intraoperative imaging. The intraoperative imaging technology can help in reducing the length of hospital stays and minimize the need for repeat surgeries, thereby reducing overall healthcare costs. Overall, the rising demand for intraoperative imaging can be attributed to its ability to improve surgical outcomes, enhance patient safety, and reduce healthcare costs, making it an increasingly attractive option for healthcare providers and patients alike. Furthermore, the number of patients receiving treatment in hospitals for neurological illnesses like epilepsy and brain tumors is on the rise. As per the WHO, epilepsy affects over 50 million individuals globally and accounts for a considerable amount of the global disease burden. The proportion of the general population with active epilepsy is estimated to be between 4 and 10 per 1000 persons. Thus, the increasing prevalence of chronic disorders and the adoption of technically advanced imaging systems are expected to boost this segment's growth during the forecast period.
Developing economies including India, Brazil, South Korea, Turkey, Russia, and South Africa provide significant development potential for intraoperative imaging market participants. Although cost is an issue in these developing countries, their large population bases-particularly in India and China-indicate a long-term market for intraoperative imaging devices. The increased frequency of chronic diseases such as cancer, stroke, nephrology, neurological surgery, and cardiovascular disorders in these countries, as well as the higher death rates, highlight the need of early identification. GLOBOCAN 2018 statistics, for example, suggested that about half of the worldwide cancer population resided in developing nations. Regulatory policies in Asia-Pacific countries are more adaptable and business-friendly than in Western countries. Increased competition in developed countries is projected to push makers of intraoperative imaging systems to focus on emerging markets.
In response to increased government pressure to cut healthcare costs, a number of healthcare providers have partnered with group buying organizations (GPOs), integrated health networks (IHNS), and integrated delivery networks (IDNS). These associations pool their members' purchases and negotiate a competitive price with medical equipment suppliers and manufacturers. For mass purchasing of intraoperative imaging devices, GPOs, IHNS, and IDNS bargain hard. The growing cost of prescription medications, combined with a steep decrease in anticipated budget allocations for health and human services in the United States for 2019, have resulted in major cuts to hospital budgets. According to an American Hospital Association analysis, federal hospital payment cuts totaling USD 218 billion by 2028, requiring hospitals to devote less resources yearly.
Based on end user, the global intraoperative imaging market is segmented into hospitals & diagnostic centers, ambulatory surgical centers & clinics, and research laboratories & academic institutes. End users in the intraoperative imaging market were dominated by hospitals and diagnostic centers. Hospitals frequently undertake a wide range of surgical operations, the majority of which are conducted in hospital inpatient settings. The increasing number of minimally invasive operations and electro surgery treatments done in hospitals, as well as the introduction of robotic surgical, are driving growth in this market. Because of their greater purchasing power and higher volume of procedures conducted, hospitals are more likely to use intraoperative imaging equipment. The increased number of orthopedic surgeries conducted in hospitals has resulted from the rising number of vehicle accidents, fall-related injuries, and sports injuries. The increased occurrence of diseases needing surgical treatment promotes the utilization by increasing the procedure volume.
Due to the presence of a large number of market players in the region, North America held the highest market share in 2022, and their consistent efforts in developing new products, investing in acquisitions, and R&D activities to support easy operations and ensure the availability of authentic medical-grade imaging systems are expected to drive the market growth. For example, Activ Surgical, a digital surgery pioneer based in the United States, announced FDA clearance of its ActivSight Intraoperative Imaging Module for improved surgical visualization in April 2021. This imaging module provides real-time intraoperative visual data and imaging to surgeons, resulting in improved patient outcomes and operating room safety.
The COVID-19 pandemic had an uneven influence on the intraoperative imaging market. While demand for imaging technologies remains high, the pandemic caused supply chain disruptions, reduced patient volumes, and financial constraints, all of which hampered market growth. Because of the rising number of COVID-19 cases globally, the pandemic spurred the demand for imaging technology in the healthcare business. Intraoperative imaging technologies are being utilized to diagnose and monitor the evolution of COVID-19 patients. Furthermore, as hospitals and healthcare facilities are converted to COVID-19 treatment, the demand for portable and mobile imaging devices has grown.
Key players in the global intraoperative imaging market include: General Electric Company, Siemens Healthineers AG, Ziehm Imaging GmbH, Medtronic, Koninklijke Philips NV, Canon Healthcare, Stryker, Brainlab AG, IMRIS, Shimadzu Corporation, Shenzhen Anke High-tech Co., FUJIFILM Holdings, Carl Zeiss Meditec AG, Mindray Ltd, Carestream Health, Analogic Corporation, Allengers Medical Systems Ltd, Esaote SpA, and Neurologica Corporation.
The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global Intraoperative Imaging Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global Intraoperative Imaging Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Table